SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

作者：Daniel Stadlbauer, Fatima Amanat, Veronika Chromikova, Kaijun Jiang, Shirin Strohmeier, Guha Asthagiri Arunkumar, Jessica Tan, Disha Bhavsar, Christina Capuano, Ericka Kirkpatrick, Philip S. Meade, Ruhi Nichalle Brito, Su Hui Catherine Teo, Meagan McMahon, Viviana R. Simon, Florian Krammer · 发表于：Current Protocols in Microbiology · 年份：2020 · DOI：10.1002/cpmc.100 · 被引用次数：818 · 研究领域：SARS-CoV-2 and COVID-19 Research、SARS-CoV-2 detection and testing、COVID-19 Clinical Research Studies

In late 2019, cases of atypical pneumonia were detected in China. The etiological agent was quickly identified as a betacoronavirus (named SARS-CoV-2), which has since caused a pandemic. Several methods allowing for the specific detection of viral nucleic acids have been established, but these only allow detection of the virus during a short period of time, generally during acute infection. Serological assays are urgently needed to conduct serosurveys, to understand the antibody responses mounted in response to the virus, and to identify individuals who are potentially immune to re-infection. Here we describe a detailed protocol for expression of antigens derived from the spike protein of SARS-CoV-2 that can serve as a substrate for immunological assays, as well as a two-stage serological enzyme-linked immunosorbent assay (ELISA). These assays can be used for research studies and for testing in clinical laboratories. © 2020 The Authors. Basic Protocol 1: Mammalian cell transfection and protein purification Basic Protocol 2: A two-stage ELISA for high-throughput screening of human serum samples for antibodies binding to the spike protein of SARS-CoV-2.